Smitirupa Mishra: Standardizing RBC Morphology Reporting – Why ICSH Guidelines Matter?
Smitirupa Mishra, Consultant Pathologist at Sparsh Hospitals and Lab Head at Pathkind Labs, shared a post on LinkedIn:
“Standardizing RBC Morphology Reporting: Why ICSH Guidelines Matter
Red blood cell morphology remains one of the most valuable components of peripheral smear examination.
However, it is also one of the areas where significant inter-observer variability exists.
Terms such as ‘few’, ‘occasional’, ‘mild’, or ‘moderate’ may mean different things to different observers, leading to confusion among clinicians and inconsistency across laboratories.
This is where the International Council for Standardization in Haematology (ICSH) guidelines play a crucial role.
The ICSH recommendations provide a standardized framework for reporting RBC morphological abnormalities, including:
- Anisocytosis
- Microcytosis and Macrocytosis
- Hypochromia
- Target cells
- Elliptocytes
- Spherocytes
- Schistocytes
- RBC inclusions and other poikilocytes
By defining percentage-based grading criteria, the guidelines help:
- Reduce subjectivity in reporting
- Improve inter-laboratory consistency
- Enhance communication with clinicians
- Facilitate better patient management and follow-up
- Strengthen quality assurance practices in hematology laboratories
One particularly important aspect is the reporting of schistocytes, where even small percentages can have significant clinical implications and may point toward life-threatening thrombotic microangiopathies.
As laboratory professionals, adopting standardized reporting systems is not merely about compliance—it is about improving diagnostic accuracy and ensuring that every morphology report conveys clear, reproducible, and clinically meaningful information.
The next time you report an RBC morphology, ask yourself:
Are we describing what we see, or are we reporting it in a standardized manner that others can interpret consistently?
Standardization transforms morphology from an art into a reproducible science.”
Stay updated with Hemostasis Today.
-
Jun 1, 2026, 15:24John Chuback: DVT Can Start With Symptoms Many People Brush Off
-
Jun 1, 2026, 15:20Venugopalan Unni: Guidelines for the Evaluation and Management of Acute Pulmonary Embolism in Adults
-
Jun 1, 2026, 14:54Davide Massimi: A Bloodless Approach to Third Space Endoscopy
-
Jun 1, 2026, 14:27Afshan Sumera: Plasma Proteomics Reveals Complement And Coagulation Disruption In Transfusion-Dependent Thalassemia
-
Jun 1, 2026, 13:44Milad Abdalla: Elevating Phlebotomy Standards – Why Order of Draw and Blood Cultures Matter
-
Jun 1, 2026, 13:39Abdul Mannan: The Moral Injury of Practising Haemato-Oncology in a Resource-Limited Setting
-
Jun 1, 2026, 13:34Filza Aslam: What Does a Patient Journey Partner Actually Do in Bleeding Disorders?
-
Jun 1, 2026, 13:33Darine Ghanem: Advancing Health Equity in Care at the LATAM Meeting
-
Jun 1, 2026, 13:23Skye Collado: Miller-Keystone Blood Center Expands Community Impact Through the Addition of New Bloodmobiles